PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Neurology Unit, Department of Neurosciences, Biomedicine, and Movement Sciences, University of Verona, Italy.\', \'Department of Medical, Surgical and Experimental Sciences, University of Sassari, Italy.\', \'Department of Medical, Surgical and Experimental Sciences, University of Sassari, Italy; Department of Medical Sciences and Public Health, University of Cagliari, Italy.\', \'Department of Neurology and Stroke Unit \'A. Cardarelli Hospital\', Naples, Italy.\', \'Neurology Unit, Department of Medical, Surgical and Health Sciences, Cattinara University Hospital, ASUGI, University of Trieste, Trieste, Italy.\', \'Multiple Sclerosis Center, ASST - Spedali Civili of Brescia, Montichiari, Brescia, Italy.\', \'Neurology Unit, Department of Neurosciences, Biomedicine, and Movement Sciences, University of Verona, Italy. Electronic address: sara.mariotto@gmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • S2211-0348(21)00690-810.1016/j.msard.2021.103424
?:doi
?:hasPublicationType
?:journal
  • Multiple sclerosis and related disorders
is ?:pmid of
?:pmid
?:pmid
  • 35216793
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.123
?:rankingScore_hIndex
  • 18
?:title
  • Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all